Combination of motherwort injection and oxytocin for the prevention of postpartum hemorrhage after cesarean section

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 15, 2016, Pages 2490-2493

  Liu, Wei ^a   Ma, Shihong ^a   Pan, Wenjing ^a   Tan, Wenhua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cesarean section; motherwort; oxytocin; postpartum hemorrhage

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; MOTHERWORT; OXYTOCIN; PLACEBO; UNCLASSIFIED DRUG; OXYTOCIC AGENT;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FEVER; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MONOTHERAPY; NAUSEA AND VOMITING; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PRIMIPARA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SHIVERING; VITAL SIGN; CHEMISTRY; COMBINATION DRUG THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEONURUS; OBSTETRIC DELIVERY; PREGNANCY;

ADULT; CESAREAN SECTION; DELIVERY, OBSTETRIC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LEONURUS; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84945207721     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2015.1090425     Document Type: Article

References (21)

1. El-Refaey H, Rodeck C. Post-partum haemorrhage: definitions, medical and surgical management A time for change. Br Med Bull 2003; 67: 205-17
2. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001; 322: 1089-93. discussion 1093-4
3. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375: 1609-23
4. Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet 2012; 287: 463-8
5. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993; 48: 15-18
6. Villar J, Valladares E, Wojdyla D, et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006; 367: 1819-29
7. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004; 112: 154-7
8. Dyer RA, van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J Obstet Anesth 2010; 19: 313-19
9. WHO. Mother-baby package: implementing safe motherhood in countries. Geneva: World Health Organization; 1994
10. Tao J, Zhang P, Liu G, et al. Cytotoxicity of Chinese motherwort (YiMuCao) aqueous ethanol extract is non-Apoptotic and estrogen receptor independent on human breast cancer cells. J Ethnopharmacol 2009; 122: 234-9
11. Wojtyniak K, Szymanski M, Matlawska I. Leonurus cardiaca L. (Motherwort): a review of its phytochemistry and pharmacology. Phytother Res 2012; 27: 1115-20
12. Chen ZS, Chen CX, Kwan CY. Leonurine, an alkaloid isolated from Leonurus artemesia induces contraction in mouse uterine smooth but relaxation in vascular smooth muscle of rat portal vein. Biomed Res 2000; 11: 209-12
13. Lin JH, Lin QD, Liu XH, et al. [Multi-center study of motherwort injection to prevent postpartum hemorrhage after caesarian section]. Zhonghua Fu Chan Ke Za Zhi 2009; 44: 175-8
14. Nordstrom L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997; 104: 781-6
15. Soriano D, Dulitzki M, Schiff E, et al A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1996; 103: 1068-73
16. Gong LX, Liao H, Zeng WY. Efficacy and safety analysis of motherwort injection combined with oxytocin on the treatment of hemorrhage during and after caesarean section. Chin J Obstet Gynecol Pediatr (Electronic Edition) 2011; 7: 173-6
17. Zhou SJ, Zheng M, Gao YX. Effect observation of drug combination preventing beforehand postpartum hemorrhage during cesarean section of patients with hypertension disease in gestation period. Matern Child Health Care China 2012; 27: 1341-2
18. Xu AQ, Zeng WY, Wu DR, et al. Primary effects of motherwort injection on uterne contraction and hemostasis. Chin J Obstet Gynecol Pediatr (Electronic Edition) 2007; 3: 88-90
19. Conde-Agudelo A, Nieto A, Rosas-Bermudez A, Romero R. Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis. Am J Obstet Gynecol 2013; 209: 40e1-e17
20. Bekassy Z, Astedt B. Treatment with the fibrinolytic inhibitor tranexamic acid-risk for thrombosis? Acta Obstet Gynecol Scand 1990; 69: 353-4
21. Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loss: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001; 36: 590-2